Immunohistochemistry (IHC) is an indispensable application routinely employed in academic and clinical research as well as in patient care. In addition to the quality of tissue section preparation, the pivotal component determining the reliability of IHC data is the suitability of the antibody used. This can only be assessed through strict and focused reagent validation.
With this in mind, GeneTex has introduced its HistoMAX product line that consists of antibodies specifically vetted for IHC. All of these reagents were extensively evaluated for IHC, utilising formalin-fixed normal and cancer tissue microarrays for good specificity and high performance. Only antibodies that have passed these stringent performance criteria for IHC will be added to the HistoMAX portfolio.
Phone: 02 9698 2022
RevMAb Biosciences histone family protein monoclonal antibodies
RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...